BNP Paribas Financial Markets
AKYA

BNP Paribas Financial Markets’s Akoya BioSciences AKYA Stock Holding History

BNP Paribas Financial Markets’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,287
Closed -$1.67K – 5555
2025
Q2 		$1.67K Sell
1,287
-797
-38% -$959 ﹤0.01% 5088
2025
Q1 		$2.9K Sell
2,084
-2,179
-51% -$4.77K ﹤0.01% 4935
2024
Q4 		$9.76K Buy
+4,263
New +$11.3K ﹤0.01% 4846
2022
Q4 		– Sell
-7,532
Closed -$88.5K – 4054
2022
Q3 		$88.5K Buy
+7,532
New +$99.2K ﹤0.01% 3823

BNP Paribas Financial Markets's AKYA Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Akoya BioSciences (AKYA) in Q3 2025, closing a stake of 1,287 shares — an estimated $1.67K sold.

BNP Paribas Financial Markets first reported a position in AKYA in Q3 2022 and held it in 4 quarters. The position peaked at $88.5K in Q3 2022. 0 funds tracked by Wall St. Rank hold AKYA as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Akoya BioSciences position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,287 Akoya BioSciences shares in Q3 2025, an estimated $1.67K.
  • BNP Paribas Financial Markets first reported a position in Akoya BioSciences in Q3 2022 and held it in 4 quarters.
  • BNP Paribas Financial Markets's Akoya BioSciences position peaked at $88.5K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.